课题基金 / 基金详情

CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS

CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
收缩末期 P-V 关系的临床应用
批准号:
6183249
负责人:
MARK R STARLING
金额:
$24.51万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 2002-03-31

项目摘要

项目成果

MARK R STARLING的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long-term goal of this research proposal is to define a time for surgery in chronic left ventricular (LV) volume overload resulting from aortic regurgitation (AR) or mitral regurgitation (MR) to preserve or restore normal LV size and performance. The natural history of LV volume overload follows a potentially identifiable hemodynamic course characterized by compensated LV hypertrophy, followed by LV systolic dysfunction in the absence of myocardial dysfunction, and finally, irreversible myocardial dysfunction. The commonly employed clinical, non- invasive, and invasive indices tend to identify patient with AR and MR late in their hemodynamic course when irreversible myocardial dysfunction predominates. In contrast, the preliminary data from this laboratory strongly support the hypotheses that LV systolic dysfunction in the absence of myocardial dysfunction can be identified in patients with AR and MR by applying both the maximum time-varying elastance and myocardial stiffness concepts, that LV systolic dysfunction in this setting is the result of inadequate LV hypertrophy and assumption of spherical geometry, and that surgery for LV volume overload at this time will reverse these detrimental hemodynamic processes and, thereby, preserve or restore normal LV size and performance. Therefore, the specific aims of this research proposal are: 1) to characterize LV chamber performance and myocardial properties using the time-varying elastance and myocardial stiffness concepts in normal patients and contrast them with those in patients with AR or MR; 2) to establish mechanisms for abnormal LV chamber elastance in the presence of normal myocardial properties; 3) to establish subgroups of patients with AR or MR based upon the presence or absence or normal LV chamber elastance and myocardial properties; 4) to define the extent and time course of changes in LV size and performance during the year following surgery for AR and MR, and 5) to characterize the independent effects of surgery for AR and MR on LV chamber elastance and myocardial properties. This research proposal represents, therefore, a unique combination of sophisticated hemodynamic approaches that are integrated to focus on providing new data to define the mechanisms for LV systolic dysfunction in the absence of myocardial dysfunction and a time for surgery in patients with AR and MR to preserve or restore normal LV size and performance.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/0002-8703(88)90339-0
发表时间: 1988
期刊: American heart journal
影响因子: 4.8
作者: [Starling,MR, Gross,MD, Walsh,RA, Mancini,GB, Blumhardt,R]
通讯作者: Blumhardt,R
Assessment of right ventricular oxidative metabolism by positron emission tomography with C-11 acetate in aortic valve disease.
使用 C-11 醋酸盐进行正电子发射断层扫描评估主动脉瓣疾病中的右心室氧化代谢。
DOI: 10.1016/0002-9149(91)90535-s
发表时间: 1991
期刊: The American journal of cardiology
影响因子: --
作者: [Hicks,RJ, Kalff,V, Savas,V, Starling,MR, Schwaiger,M]
通讯作者: Schwaiger,M
Relation between maximum time-varying elastance pressure-volume areas and myocardial oxygen consumption in dogs.
狗最大时变弹性压力-体积面积与心肌耗氧量之间的关系。
DOI: 10.1161/01.cir.83.1.304
发表时间: 1991
期刊: Circulation
影响因子: 37.8
作者: [Starling,MR, Mancini,GB, Montgomery,DG, Gross,MD]
通讯作者: Gross,MD
Dissociation of end systole from end ejection in patients with long-term mitral regurgitation.
长期二尖瓣反流患者收缩末期与射血末期的分离。
DOI: 10.1161/01.cir.81.4.1277
发表时间: 1990
期刊: Circulation
影响因子: 37.8
作者: [Brickner,ME, Starling,MR]
通讯作者: Starling,MR
22
    EFFECT OF AMLODIPINE ON SURVIVAL IN PATIENTS WITH CONGESTIVE HEART FAILURE
    EFFECT OF AMLODIPINE ON SURVIVAL IN PATIENTS WITH CONGESTIVE HEART FAILURE
    CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
    CLINICAL APPLICATION OF END SYSTOLIC P-V RELATIONS
    海外基金